Die Bewertung der Kosteneffektivität von Impfungen unter Berücksichtigung von Public Health Aspekten

Literaturverzeichnis

[1] Willems JS, Sanders CR, Riddiough MA, Bell JC. Cost effectiveness of vaccination against pneumococcal pneumonia. N Engl J Med. 1980 Sep 4; 303 (10): 553–9.10.1056/NEJM198009043031004Search in Google Scholar

[2] Arnold H. [Influenza vaccination: effect, costs and benefits?]. Offentl Gesundheitswes. 1977 Nov; 39 (11): 733–4.Search in Google Scholar

[3] Wiedermann G. [Modern trends in vaccination policy: evaluation of benefits, risks and cost (author's transl)]. Wien Klin Wochenschr. 1979 Mar 2; 91 (5): 143–50.Search in Google Scholar

[4] Dejonghe P., Parkinson B. "Benefits and costs of vaccination" Vaccine., vol. 10, no. 13, 1992, p. 936–93910.1016/0264-410X(92)90328-H. Search in Google Scholar

[5] Ehreth J. The value of vaccination: a global perspective. Vaccine. 2003 Oct 1; 21 (27–30): 4105–17.10.1016/S0264-410X(03)00377-3Search in Google Scholar

[6] Ehreth J. The global value of vaccination. Vaccine. 2003 Jan 30; 21 (7–8): 596–600.10.1016/S0264-410X(02)00623-0Search in Google Scholar

[7] Batson A. Win-win interactions between the public and private sectors. Nat Med. 1998 May; 4 (5 Suppl): 487–91.10.1038/nm0598supp-487Search in Google Scholar

[8] Coffield AB, Maciosek MV, McGinnis JM, Harris JR, Caldwell MB, Teutsch SM, et al. Priorities among recommended clinical preventive services. Am J Prev Med. 2001 Jul; 21 (1): 1–9.10.1016/S0749-3797(01)00308-7Search in Google Scholar

[9] Chabot I, Goetghebeur MM, Gregoire JP. The societal value of universal childhood vaccination. Vaccine. 2004 May 7; 22 (15–16): 1992–2005.10.1016/j.vaccine.2003.10.027Search in Google Scholar

[10] Drummond M, Chevat C, Lothgren M. Do we fully understand the economic value of vaccines? Vaccine. 2007 Aug 10; 25 (32): 5945–57.10.1016/j.vaccine.2007.04.070Search in Google Scholar

[11] Kim S.Y., Goldie S.J. "Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches" Pharmacoeconomics, vol. 26, no. 3, 2008, p. 191–21510.2165/00019053-200826030-00004. Search in Google Scholar

[12] Edmunds WJ, Medley GF, Nokes DJ. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat Med. 1999 Dec 15; 18 (23): 3263–82.10.1002/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3Search in Google Scholar

[13] Siebert U. When should decision-analytic modeling be used in the economic evaluation of health care? [Editorial]. European Journal of Health Economics. 2003 Sep; 4 (3): 143–50.10.1007/s10198-003-0205-2Search in Google Scholar

[14] Siebert U. Transparente Entscheidungen in Public Health mittels systematischer Entscheidungsanalyse. In: Schwartz FW, Badura B, Leidl R, Raspe H, Siegrist J, Walter U, editors. Das Public Health Buch Gesundheit und Gesundheitswesen. 2nd ed. München: Urban & Fischer; 2003. p. 485–502.Search in Google Scholar

[15] Stahl J.E. "Modelling methods for pharmacoeconomics and health technology assessment: an overview and guide" Pharmacoeconomics, vol. 26, no. 2, 2008, p. 131–14810.2165/00019053-200826020-00004. Search in Google Scholar PubMed

[16] Brennan A, Chick SE, Davies R. A taxonomy of model structures for economic evaluation of health technologies. Health Econ. 2006 Dec; 15 (12): 1295–310.10.1002/hec.1148Search in Google Scholar PubMed

[17] Cohen D.R., Henderson J.B. "Health Prevention and Economics" , 1988 Oxford University Press: Oxford. Search in Google Scholar

[18] Techakehakij W, Feldman RD. Cost-effectiveness of HPV vaccination compared with Pap smear screening on a national scale: a literature review. Vaccine. 2008 Nov 18; 26 (49): 6258–65.10.1016/j.vaccine.2008.09.036Search in Google Scholar PubMed

[19] Ament A, Baltussen R, Duru G, Rigaud-Bully C, de Graeve D, Ortqvist A, et al. Cost-effectiveness of pneumococcal vaccination of older people: a study in 5 western European countries. Clin Infect Dis. 2000 Aug; 31 (2): 444–50.10.1086/313977Search in Google Scholar PubMed

[20] Evers SM, Ament AJ, Colombo GL, Konradsen HB, Reinert RR, Sauerland D, et al. Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries. Eur J Clin Microbiol Infect Dis. 2007 Aug; 26 (8): 531–40.10.1007/s10096-007-0327-zSearch in Google Scholar PubMed

[21] Beutels P, Van Doorslaer E, Van Damme P, Hall J. Methodological issues and new developments in the economic evaluation of vaccines. Expert Rev Vaccines. 2003 Oct; 2 (5): 649–60.10.1586/14760584.2.5.649Search in Google Scholar PubMed

[22] Ortega-Sanchez IR, Lee GM, Jacobs RJ, Prosser LA, Molinari NA, Zhang X, et al. Projected cost-effectiveness of new vaccines for adolescents in the United States. Pediatrics. 2008 Jan; 121 Suppl 1: S63–78.10.1542/peds.2007-1115HSearch in Google Scholar PubMed